Journal
RESPIROLOGY
Volume 11, Issue -, Pages S12-S15Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1440-1843.2006.00800.x
Keywords
epithelial cells; phospholipids; surfactant
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL067671, R01HL029891, P01HL067671, R37HL029891] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI059576] Funding Source: NIH RePORTER
- NHLBI NIH HHS [HL-29891, HL-67671] Funding Source: Medline
- NIAID NIH HHS [P01-AI059576] Funding Source: Medline
Ask authors/readers for more resources
The purpose of this review is to highlight the many metabolic properties of alveolar type II cells, their production of surfactant, their role in innate immunity and their importance in the repair process after lung injury The review is based on the medical literature and results from our laboratory. Type 11 cells produce and secrete pulmonary surfactant and for that purpose they need to synthesize the lipids of surfactant. One of the regulators of lipogenesis is the transcription factor sterol regulatory element binding protein-1c (SREBP-1c). This is a key transcription factor regulating fatty acid synthesis. Type II cells also proliferate to restore the epithelium after lung injury, clear alveolar fluid by transporting sodium from the apical to the basolateral surface, and participate in the innate immune response to inhaled materials and organisms. The type 11 cell is, in many ways, the defender of the alveolus. However, the type 11 cells work in concert with the other cells in the gas exchange regions of the lung to keep the alveoli open and reduce inflammation due to irritants in the air we breathe.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available